ARCHIVES

Kulig Will Oversee Outcomes Research at NCCN

This article is from The Cancer Letter archive.

Vol. 37 No. 36 | September 30, 2011

Download PDF Visit The Full Archive

Related Articles

Cetuximab Plus Chemoradiation Boosts Survival in Phase II Study

June 24, 2011

Funding Exceptions, Skipovers, While Limited At NCI, Become Crucial Issues; NCAB To Be Brief On Details

January 7, 1983

Text of concept statement included in this 8-page issue.

July 16, 2004

Roswell Park Researchers Win $1.6M For Tobacco Studies.

June 20, 2003

Don’t Blame FDA For All Problems, Broder Says

September 7, 1990

NCI Study Find Farmers Using Herbicides At High Risk for Some Lymphomas

September 12, 1986